Reuters logo
BRIEF-Prometrika to coordinate second Phase I trial for MD Anderson's Institute for Applied Cancer Science
October 16, 2017 / 9:12 PM / a month ago

BRIEF-Prometrika to coordinate second Phase I trial for MD Anderson's Institute for Applied Cancer Science

Oct 16 (Reuters) - Prometrika Llc-

* Prometrika to coordinate second Phase I trial for MD Anderson’s Institute For Applied Cancer Science Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below